PSICOR announces participation
Selected Abstract
PSICOR announces participation in hyperthermia trials for AIDS patients.
SAN DIEGOBUSINESS WIREJan. 25, 1995--PSICOR Inc. (NASDAQ/PCOR) Wednesday announced that it has agreed to assist HemoCleanse Inc. of West Lafayette, Ind., and its marketing partner, IDT, a subsidiary of BioControl Technology Inc. of Pittsburgh, in the clinical trials of HemoCleanse's BioLogic-HT ... January 25, 1995; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
PSICOR announces participation in hyperthermia trials for AIDS patients.
|
